Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕Aditya Birla Sun Life PSU Equity Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaABSL
NAV₹591.2429₹37.5900
NAV date20 Nov 202620 Nov 2026
History20.6 years6.9 years
Expense ratio1.8%1.9%
Stars★★★★★★★★★★
Growth Score78.1066.90

Returns

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
1 month+11.32%+9.59%
3 months+3.52%+4.04%
6 months+8.09%+4.21%
YTD+16.05%+8.42%
1 year+14.27%+7.99%
3 years (CAGR)+16.91%+18.52%
5 years (CAGR)+14.37%+21.99%
10 years (CAGR)+15.58%—
Since launch+17.64%+21.10%

Risk

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
Volatility14.1%22.7%
Downside volatility9.1%13.4%
Sharpe0.740.53
Sortino1.150.90
Calmar1.140.68
Return / risk1.200.82
Deepest fall−47.36%−33.99%
Days to recover301288
Below its high+0.00%−1.29%

Against benchmark

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
Alpha−2.75%—
Beta0.89—
R²89.5%—
Up capture83.5%—
Down capture91.2%—
Tracking error4.8%—
Information ratio−0.88—
Treynor0.11—

Consistency

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
Best 1-year+175.79%+108.60%
Middle 1-year+13.84%+23.18%
Worst 1-year−36.67%−16.19%
1-year periods with a loss23.4%13.8%
Middle 3-year+20.93%+30.31%
Positive months63.9%55.6%
Best day+3.40%+6.88%
Worst day−3.21%−14.62%
Worst 5% day−1.38%−2.02%
Positive days53.7%55.8%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
5-year XIRR+17.18%+19.29%
5-year value₹9,29,284₹9,79,396
3-year XIRR+13.26%+9.10%
1-year XIRR+21.05%+10.53%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth